Clinical Trial Update: Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of CLONICEL for children and adolescents with Attention-Deficit/Hyperactivity Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CLONICEL (clonidine sustained-release)

Snippet

Sponsor: Addrenex Pharmaceuticals, Inc. | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED